Drugs / IN-B001 EV71
last change Dec 2021 re-read 3 minutes ago

IN-B001 EV71

Vaccine

Developed for
hand, foot and mouth disease
Investigated by
HK inno.N Corporation

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04637919 Dec 2020 → Dec 2021 hand, foot and mouth disease HK inno.N Corporation Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IN-B001 EV71 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04637919 ↗
Modality Vaccine “Inactivated vaccine against EV71” NCT04637919 ↗